AUMED

AUMED is a Czech biotechnology company specialized in the research, development, and production of innovative pharmaceutical and diagnostic products with a primary focus on bacteriophage therapy. The company addresses the growing global threat of antibiotic resistance by developing phage-based preparations that specifically target pathogenic bacteria like Staphylococcus aureus while preserving natural microflora. Beyond its phage platform, AUMED develops immunomodulatory products and food supplements designed to support the human immune system and manage chronic inflammatory conditions. The company operates high-end R&D laboratories and manufacturing facilities, collaborating with academic institutions to translate advanced microbiological research into clinical applications.